Tactile Medical Bundle
Who Owns Tactile Medical?
Understanding Tactile Medical's ownership is key to grasping its strategic path and accountability in the medical tech sector. Its 2016 IPO marked a significant shift, moving control from private investors to public shareholders.
Founded in 1995 and based in Minneapolis, Minnesota, Tactile Medical is dedicated to at-home therapies for chronic conditions, aiming to enhance patient quality of life. The company's core offerings include prescribed devices for lymphedema and chronic venous insufficiency, notably its Flexitouch system, a pneumatic compression device.
As of July 2025, Tactile Medical operates as a publicly traded entity, with its ownership spread across institutional and individual shareholders. This public status means no single entity holds a majority stake, reflecting a diverse investor base. The company's journey from its inception, through early investment rounds, to its current public standing highlights a dynamic ownership evolution.
Who Founded Tactile Medical?
Tactile Medical, originally incorporated in Minnesota in 1995 and later reincorporated in Delaware in 2006 as Tactile Systems Technology, Inc., began its journey with a focus on at-home chronic disease treatments. While the specific details of all founders and their initial equity stakes are not publicly detailed, the company's early development was fueled by significant seed funding.
Founding and Incorporation
The company was first incorporated in Minnesota in January 1995. It later reincorporated in Delaware in July 2006, adopting the name Tactile Systems Technology, Inc.
Initial Funding Rounds
Tactile Medical secured substantial early funding, totaling $23.2 million across three distinct rounds. The first funding round occurred on October 30, 2007.
Key Investors
Notable early institutional investors included Radius Ventures, Galen Partners, and Sofia Fund. Radius Ventures was the lead investor in the company's latest funding round.
Focus on At-Home Therapies
From its inception, the company's mission centered on developing medical devices for the at-home treatment of chronic diseases. This focus guided its technological advancements, such as the development of the Flexitouch system.
Early Ownership Concentration
The initial ownership structure likely saw a concentration among the founders and the venture capital firms that provided early-stage funding. These entities shared a vision for improving chronic condition management.
Series B Funding
The company's latest funding round, a Series B, took place on October 16, 2012, and successfully raised $10.4 million. This capital infusion was critical for further development and market expansion.
The early ownership of Tactile Medical was shaped by its founders and the venture capital firms that invested in its innovative approach to chronic disease management. These early backers, including Radius Ventures, Galen Partners, and Sofia Fund, provided essential capital that allowed the company to grow and refine its technologies, such as the Flexitouch system. This period laid the groundwork for the company's future trajectory, establishing a foundation built on addressing unmet needs in at-home healthcare. For a deeper understanding of the company's origins, refer to the Brief History of Tactile Medical.
Tactile Medical SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Tactile Medical’s Ownership Changed Over Time?
Tactile Medical's ownership trajectory shifted significantly with its Initial Public Offering (IPO) on July 28, 2016, when its common stock commenced trading on The NASDAQ Global Market under the ticker symbol 'TCMD'. This event marked the transition to a publicly traded entity, fundamentally altering its ownership structure.
| Event | Date | Impact on Ownership |
|---|---|---|
| Initial Public Offering (IPO) | July 28, 2016 | Shares began trading publicly; Tactile Medical sold 4,120,000 shares at $10.00 per share. |
| Public Offering of Common Stock | February 2023 | 2,500,000 shares sold at $13.00 per share, raising $32.5 million to fund expansion and development. |
As of July 15, 2025, Tactile Medical's ownership is predominantly held by institutional investors, who collectively own 97.12% of the company's outstanding common stock. Insider ownership represents a smaller portion at 2.59%. This high level of institutional backing signifies that major investment firms, including mutual funds and hedge funds, are key stakeholders. For example, Dimensional Fund Advisors LP (DFA) held 1,572,330 shares as of June 30, 2025, accounting for 5.1% of the total shares and exercising sole voting power over 1,540,879 of those shares. The active management of these stakes is evident in the first quarter of 2025, with 61 institutional investors increasing their positions and 72 reducing them, reflecting dynamic trading strategies among large investment entities. Understanding these shifts is crucial for grasping the Target Market of Tactile Medical and its investor base.
Key Stakeholder Information
Institutional investors are the primary owners of Tactile Medical, holding a substantial majority of the company's stock.
- Institutional Ownership: 97.12% (as of July 15, 2025)
- Insider Ownership: 2.59% (as of July 15, 2025)
- Dimensional Fund Advisors LP (DFA) beneficially owned 5.1% of outstanding shares as of June 30, 2025.
- Market capitalization as of July 2025 is approximately $230-245 million USD.
Tactile Medical PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Tactile Medical’s Board?
The current board of directors at Tactile Medical is responsible for the company's governance and oversight. As of March 28, 2025, the board comprises eight directors, each elected annually for a one-year term. Key members include William W. Burke, Chairman of the Board since May 2021, and Sheri L. Dodd, who also serves as Chief Executive Officer since July 2024 and has been a board member since 2021.
| Director Name | Role | Appointment/Tenure Start |
|---|---|---|
| William W. Burke | Chairman of the Board | May 2021 |
| Sheri L. Dodd | Chief Executive Officer & Board Member | July 2024 (CEO), 2021 (Board) |
| Valerie L. Asbury | Director | |
| Raymond O. Huggenberger | Director | |
| Laura G. King | Director | January 2025 |
| D. Brent Shafer | Director | |
| Carmen B. Volkart | Director | |
| B. Vindell Washington | Director |
Tactile Medical operates on a one-share-one-vote principle, meaning each share of common stock held by a stockholder of record grants one vote. As of March 13, 2025, there were 23,665,798 shares of common stock outstanding and eligible to vote. A quorum for conducting business requires a majority of the total voting power of issued and outstanding shares. The company's bylaws protect directors from easy removal, requiring an affirmative vote of at least 75% of the votes stockholders could cast in an election to remove a director for cause. There is no evidence of dual-class shares or other structures that would grant disproportionate control to any specific individuals or entities beyond their proportional shareholdings. Insider trading activity in the six months leading up to July 21, 2025, indicated nine sales by insiders with no reported purchases. For example, Daniel L. Reuvers, former CEO and current board member, sold 39,276 shares, valued at approximately $560,996.
Understanding Tactile Medical Ownership
The ownership structure of Tactile Medical is determined by its common stock. Understanding who owns Tactile Medical provides insight into its governance and strategic direction.
- Tactile Medical stock ownership is based on a one-share-one-vote system.
- The board of directors oversees company operations and strategy.
- Insider transactions can offer clues about management's confidence.
- Shareholder voting power is directly tied to the number of shares held.
- For more on the company's guiding principles, explore the Mission, Vision & Core Values of Tactile Medical.
Tactile Medical Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Tactile Medical’s Ownership Landscape?
Recent developments at Tactile Medical have seen significant leadership transitions and strategic financial maneuvers. The company appointed a new CEO and repurchased a substantial amount of its stock, indicating active management of its ownership structure and future growth plans.
| Ownership Type | Percentage | Change in Q1 2025 |
|---|---|---|
| Institutional Ownership | 97.12% (as of July 15, 2025) | 61 investors added shares, 72 decreased positions |
| Insider Ownership | 2.59% | N/A |
The company's ownership profile is heavily weighted towards institutional investors, reflecting broad market confidence. Insider ownership remains a smaller, yet significant, component. These figures are dynamic, with active trading by institutional holders influencing the overall Tactile Medical stock ownership landscape.
Leadership Transition
Sheri Dodd assumed the role of CEO on July 1, 2024, succeeding Dan Reuvers. Mr. Reuvers continues to serve on the board and as an advisor until March 31, 2025.
Share Repurchase Program
In the first quarter of 2025, Tactile Medical executed a share repurchase totaling $10.0 million. This action can impact the proportional ownership of remaining shareholders.
Public Offering and Funding
A public offering in February 2023 raised $32.5 million from the sale of 2,500,000 shares. These funds are designated for commercial expansion and product development.
Market Expansion and Financial Outlook
The company expanded its Nimbl platform in January 2025 and projects full-year 2025 revenue between $309 million and $315 million. This growth strategy is detailed in an article on the Growth Strategy of Tactile Medical.
Tactile Medical Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Tactile Medical Company?
- What is Competitive Landscape of Tactile Medical Company?
- What is Growth Strategy and Future Prospects of Tactile Medical Company?
- How Does Tactile Medical Company Work?
- What is Sales and Marketing Strategy of Tactile Medical Company?
- What are Mission Vision & Core Values of Tactile Medical Company?
- What is Customer Demographics and Target Market of Tactile Medical Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.